Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1101 13 |
Ultima descărcare din IBN: 2021-05-11 13:17 |
SM ISO690:2012 MUNTEANU, Olesea, BACINSCHI-GHEORGHIȚA, Stela. Preparatele antifibrotice – actualităţi şi perspective. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2009, nr. 1(10), pp. 293-300. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 1(10) / 2009 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 293-300 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Antifibrotic preparation – actualities and perspectives
Antifibrotic medication may be effectuated through the elucidation of antifibrotic activity of the drugs used, and through elaboration of the new remedies capable to influence mechanisms of fibroses. The first direction is realized through the drugs usage: antivirale (interferon, analogues, nucleozides); anti-inflammatory drugs (glucocorticoids, AINS, colchicines); antioxidants (tocoferol, pentoxiphylline, biciclol etc.), hepatoprotectors (silimarine, essenciale, ursodeoxycolic acid, ademetionine etc) and inhibitors of rennin-angiotensin-aldosteron (aliskeren, captopril, enalapril, lozartan, valsartan etc.) The second direction includes experimental and clinical researches of TNF alfa antagonists (inflimax etc.) antagonists and cytokines receptors blockers, endothelial receptors antagonists, inhibitors of tissue protease and tirozinkinase. |
||||||
|